Cidara Therapeutics (CDTX) Stock Chart & Stock Price History $16.52 +0.09 (+0.55%) Closing price 04:00 PM EasternExtended Trading$16.58 +0.05 (+0.33%) As of 05:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Cidara Therapeutics Stock Price Performance 5 Day Performance-10.07%1 Month Performance-30.18%3 Month Performance-38.81%6 Month Performance+48.43%Year-To-Date Performance-38.54%1 Year Performance-28.79% Receive CDTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cidara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address CDTX Stock Chart for Monday, April, 7, 2025 CDTX Chart by TradingViewRemove Ads Cidara Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/04/2025$17.82$16.43-7.80%$17.20$16.10119,539 shs$179.96 million04/03/2025$18.37$17.82-2.99%$18.42$17.50168,560 shs$195.18 million04/02/2025$18.92$18.37-2.91%$19.21$18.03135,097 shs$201.21 million04/01/2025$21.54$18.92-12.16%$22.04$18.78151,452 shs$207.23 million03/31/2025$22.39$21.54-3.80%$22.64$21.0488,056 shs$235.93 million03/28/2025$21.58$22.39+3.75%$22.64$21.5077,383 shs$245.24 million03/27/2025$20.83$21.58+3.60%$21.93$19.8367,453 shs$236.37 million03/26/2025$22.03$20.83-5.45%$22.23$20.67201,515 shs$228.15 million03/25/2025$23.63$22.03-6.77%$23.50$21.76210,562 shs$241.30 million03/24/2025$22.47$23.63+5.16%$23.76$22.40104,525 shs$258.82 million Get the Latest News and Ratings for CDTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cidara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/21/2025$23.10$22.47-2.73%$23.50$21.20197,853 shs$246.11 million03/20/2025$22.75$23.10+1.54%$23.49$22.28816,820 shs$253.01 million03/19/2025$22.75$22.75$23.22$22.04188,688 shs$249.18 million03/18/2025$22.27$22.75+2.16%$23.25$21.9182,483 shs$249.18 million03/17/2025$22.05$22.27+1.00%$22.59$21.3090,681 shs$156.94 million03/14/2025$22.36$22.05-1.39%$22.70$22.0460,726 shs$155.39 million03/13/2025$23.00$22.36-2.78%$23.44$21.7684,965 shs$162.07 million03/12/2025$21.00$23.00+9.52%$23.66$21.00148,656 shs$162.08 million03/11/2025$22.39$21.00-6.21%$21.96$20.15126,939 shs$147.99 million03/10/2025$23.66$22.39-5.37%$24.14$21.78106,453 shs$157.78 million03/07/2025$23.61$23.66+0.21%$23.94$21.8552,851 shs$166.73 million03/06/2025$23.50$23.61+0.47%$24.00$23.1151,232 shs$166.38 million Related Companies Collegium Pharmaceutical Stock Chart Nurix Therapeutics Stock Chart Vir Biotechnology Stock Chart Phibro Animal Health Stock Chart Xeris Biopharma Stock Chart Oculis Stock Chart Zymeworks Stock Chart Arcus Biosciences Stock Chart Pharvaris Stock Chart Day One Biopharmaceuticals Stock Chart Receive CDTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cidara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CDTX) was last updated on 4/7/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cidara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cidara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CDTX Stock Free CDTX Stock Alerts